CD38 is methylated in prostate cancer and regulates extracellular NAD+

Cited by papers we hold 5

• Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts · 2022
  No notice
• NAD+ metabolism, stemness, the immune response, and cancer · 2021
  No notice
• NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation · 2020
  No notice
• The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases · 2019
  No notice
• NAD Metabolism in Cancer Therapeutics · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.